Competent Cells Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Chemically Competent Cells and Electrocompetent Cells) Application (Cloning, Protein Expression and Other Applications) End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies and Contract Research Organizations)\n

Report Code: TIPBT00002547 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Cells that are more likely to incorporate foreign DNA if their cell walls have been modified to enable DNA to pass through more easily. This cells are referred to as capable. Cells become capable by a mechanism that involves the use of calcium chloride and heat shock. Cells that are undergoing accelerated growth are more quickly rendered capable than cells at other stages of development.

MARKET SCOPE

The "Global Competent Cells Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Competent Cells market with detailed market segmentation by type, application, end user and geography. The report provides key statistics on the market status of the leading Competent Cells market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on type, the global competent cells market is segmented into chemically competent cells and electrocompetent cells).
  • On the basis of application, the market is segmented into cloning, protein expression and other applications.
  • On the basis of end user, the market is segmented into academic research institutes, pharmaceutical & biotechnology companies and contract research organizations.

MARKET DYNAMICS

Drivers

  • The advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins.
  • Various technological developments in the healthcare industry in Asia Pacific and Europe
  • Rise in government investment in research activities

Restraints

  • High cost of cloning based research and shortage of skilled professionals for handling of competent cells

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Competent Cells market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Competent Cells market in these regions.

IMPACT OF COVID-19 ON COMPETENT CELLS MARKET

Biopharmaceutical innovators are leading the human response to the coronavirus pandemic. Numerous large pharmaceutical firms are racing to get a better understanding of the Sars-Cov-2 genome and to produce a vaccine. In contrast to how quickly biotech companies responded to SARS/MERS, etc., biotech companies are studying SARs-Cov-2 at an unprecedented rate and investing large funds in research and development. With multiple candidates in clinical trials, it is likely that the public and private sectors will collaborate in the immediate future, at least before a vaccine for Covid-19 is created.

MARKET PLAYERS

The report covers key developments in the competent cells market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Competent Cells market are anticipated to lucrative growth opportunities in the future with the rising demand for Competent Cells in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Competent Cells market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Merck KGaA
  • Promega Corporation
  • Takara Bio, Inc.
  • New England Biolabs
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies
  • Illumina, Inc.
  • Qiagen
  • Genscript
  • Origene Technologies, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Electrocompetent Cells Market - By Product Type
 1.3.2 Electrocompetent Cells Market - By End users/Applications
 1.3.3 Electrocompetent Cells Market - By Region
 1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ELECTROCOMPETENT CELLS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. ELECTROCOMPETENT CELLS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ELECTROCOMPETENT CELLS MARKET - GLOBAL MARKET ANALYSIS
 6.1. ELECTROCOMPETENT CELLS - GLOBAL MARKET OVERVIEW
 6.2. ELECTROCOMPETENT CELLS - GLOBAL MARKET AND FORECAST TO 2028
 6.3. MARKET POSITIONING
7. ELECTROCOMPETENT CELLS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
 7.1. OVERVIEW
 7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
 7.3. CLONED COMPETENT CELLS
 7.3.1. Overview
 7.3.2. Cloned Competent Cells Market Forecast and Analysis
 7.4. AGROBACTERIUM TUMEFACIENS COMPETENT CELLS
 7.4.1. Overview
 7.4.2. Agrobacterium tumefaciens Competent Cells Market Forecast and Analysis
 7.5. EXPRESSION COMPETENT CELLS
 7.5.1. Overview
 7.5.2. Expression Competent Cells Market Forecast and Analysis
8. ELECTROCOMPETENT CELLS MARKET - REVENUE AND FORECASTS TO 2028 - END USERS/APPLICATIONS
 8.1. OVERVIEW
 8.2. END USERS/APPLICATIONS MARKET FORECASTS AND ANALYSIS
 8.3. SUBCLONING AND ROUTINE CLONING
 8.3.1. Overview
 8.3.2. Subcloning and Routine Cloning Market Forecast and Analysis
 8.4. PHAGE DISPLAY LIBRARY CONSTRUCTION
 8.4.1. Overview
 8.4.2. Phage Display Library Construction Market Forecast and Analysis
 8.5. TOXIC/UNSTABLE DNA CLONING
 8.5.1. Overview
 8.5.2. Toxic/Unstable Dna Cloning Market Forecast and Analysis
 8.6. HIGH-THROUGHPUT CLONING
 8.6.1. Overview
 8.6.2. High-Throughput Cloning Market Forecast and Analysis
 8.7. PROTEIN EXPRESSION
 8.7.1. Overview
 8.7.2. Protein Expression Market Forecast and Analysis
 8.8. MUTAGENESIS
 8.8.1. Overview
 8.8.2. Mutagenesis Market Forecast and Analysis
 8.9. SINGLE-STRANDED DNA PRODUCTION
 8.9.1. Overview
 8.9.2. Single-Stranded Dna Production Market Forecast and Analysis
 8.10. BACMID CREATION
 8.10.1. Overview
 8.10.2. Bacmid creation Market Forecast and Analysis
 8.11. CRE-LOX RECOMBINATION (PIR1/PIR2)
 8.11.1. Overview
 8.11.2. Cre-lox recombination (PIR1/PIR2) Market Forecast and Analysis
9. ELECTROCOMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
 9.1. NORTH AMERICA
 9.1.1 North America Electrocompetent Cells Market Overview
 9.1.2 North America Electrocompetent Cells Market Forecasts and Analysis
 9.1.3 North America Electrocompetent Cells Market Forecasts and Analysis - By Product Type
 9.1.4 North America Electrocompetent Cells Market Forecasts and Analysis - By End users/Applications
 9.1.5 North America Electrocompetent Cells Market Forecasts and Analysis - By Countries
 9.1.5.1 United States Electrocompetent Cells Market
 9.1.5.1.1 United States Electrocompetent Cells Market by Product Type
 9.1.5.1.2 United States Electrocompetent Cells Market by End users/Applications
 9.1.5.2 Canada Electrocompetent Cells Market
 9.1.5.2.1 Canada Electrocompetent Cells Market by Product Type
 9.1.5.2.2 Canada Electrocompetent Cells Market by End users/Applications
 9.1.5.3 Mexico Electrocompetent Cells Market
 9.1.5.3.1 Mexico Electrocompetent Cells Market by Product Type
 9.1.5.3.2 Mexico Electrocompetent Cells Market by End users/Applications
 9.2. EUROPE
 9.2.1 Europe Electrocompetent Cells Market Overview
 9.2.2 Europe Electrocompetent Cells Market Forecasts and Analysis
 9.2.3 Europe Electrocompetent Cells Market Forecasts and Analysis - By Product Type
 9.2.4 Europe Electrocompetent Cells Market Forecasts and Analysis - By End users/Applications
 9.2.5 Europe Electrocompetent Cells Market Forecasts and Analysis - By Countries
 9.2.5.1 Germany Electrocompetent Cells Market
 9.2.5.1.1 Germany Electrocompetent Cells Market by Product Type
 9.2.5.1.2 Germany Electrocompetent Cells Market by End users/Applications
 9.2.5.2 France Electrocompetent Cells Market
 9.2.5.2.1 France Electrocompetent Cells Market by Product Type
 9.2.5.2.2 France Electrocompetent Cells Market by End users/Applications
 9.2.5.3 Italy Electrocompetent Cells Market
 9.2.5.3.1 Italy Electrocompetent Cells Market by Product Type
 9.2.5.3.2 Italy Electrocompetent Cells Market by End users/Applications
 9.2.5.4 Spain Electrocompetent Cells Market
 9.2.5.4.1 Spain Electrocompetent Cells Market by Product Type
 9.2.5.4.2 Spain Electrocompetent Cells Market by End users/Applications
 9.2.5.5 United Kingdom Electrocompetent Cells Market
 9.2.5.5.1 United Kingdom Electrocompetent Cells Market by Product Type
 9.2.5.5.2 United Kingdom Electrocompetent Cells Market by End users/Applications
 9.3. ASIA-PACIFIC
 9.3.1 Asia-Pacific Electrocompetent Cells Market Overview
 9.3.2 Asia-Pacific Electrocompetent Cells Market Forecasts and Analysis
 9.3.3 Asia-Pacific Electrocompetent Cells Market Forecasts and Analysis - By Product Type
 9.3.4 Asia-Pacific Electrocompetent Cells Market Forecasts and Analysis - By End users/Applications
 9.3.5 Asia-Pacific Electrocompetent Cells Market Forecasts and Analysis - By Countries
 9.3.5.1 Australia Electrocompetent Cells Market
 9.3.5.1.1 Australia Electrocompetent Cells Market by Product Type
 9.3.5.1.2 Australia Electrocompetent Cells Market by End users/Applications
 9.3.5.2 China Electrocompetent Cells Market
 9.3.5.2.1 China Electrocompetent Cells Market by Product Type
 9.3.5.2.2 China Electrocompetent Cells Market by End users/Applications
 9.3.5.3 India Electrocompetent Cells Market
 9.3.5.3.1 India Electrocompetent Cells Market by Product Type
 9.3.5.3.2 India Electrocompetent Cells Market by End users/Applications
 9.3.5.4 Japan Electrocompetent Cells Market
 9.3.5.4.1 Japan Electrocompetent Cells Market by Product Type
 9.3.5.4.2 Japan Electrocompetent Cells Market by End users/Applications
 9.3.5.5 South Korea Electrocompetent Cells Market
 9.3.5.5.1 South Korea Electrocompetent Cells Market by Product Type
 9.3.5.5.2 South Korea Electrocompetent Cells Market by End users/Applications
 9.4. MIDDLE EAST AND AFRICA
 9.4.1 Middle East and Africa Electrocompetent Cells Market Overview
 9.4.2 Middle East and Africa Electrocompetent Cells Market Forecasts and Analysis
 9.4.3 Middle East and Africa Electrocompetent Cells Market Forecasts and Analysis - By Product Type
 9.4.4 Middle East and Africa Electrocompetent Cells Market Forecasts and Analysis - By End users/Applications
 9.4.5 Middle East and Africa Electrocompetent Cells Market Forecasts and Analysis - By Countries
 9.4.5.1 South Africa Electrocompetent Cells Market
 9.4.5.1.1 South Africa Electrocompetent Cells Market by Product Type
 9.4.5.1.2 South Africa Electrocompetent Cells Market by End users/Applications
 9.4.5.2 Saudi Arabia Electrocompetent Cells Market
 9.4.5.2.1 Saudi Arabia Electrocompetent Cells Market by Product Type
 9.4.5.2.2 Saudi Arabia Electrocompetent Cells Market by End users/Applications
 9.4.5.3 U.A.E Electrocompetent Cells Market
 9.4.5.3.1 U.A.E Electrocompetent Cells Market by Product Type
 9.4.5.3.2 U.A.E Electrocompetent Cells Market by End users/Applications
 9.5. SOUTH AND CENTRAL AMERICA
 9.5.1 South and Central America Electrocompetent Cells Market Overview
 9.5.2 South and Central America Electrocompetent Cells Market Forecasts and Analysis
 9.5.3 South and Central America Electrocompetent Cells Market Forecasts and Analysis - By Product Type
 9.5.4 South and Central America Electrocompetent Cells Market Forecasts and Analysis - By End users/Applications
 9.5.5 South and Central America Electrocompetent Cells Market Forecasts and Analysis - By Countries
 9.5.5.1 Brazil Electrocompetent Cells Market
 9.5.5.1.1 Brazil Electrocompetent Cells Market by Product Type
 9.5.5.1.2 Brazil Electrocompetent Cells Market by End users/Applications
 9.5.5.2 Argentina Electrocompetent Cells Market
 9.5.5.2.1 Argentina Electrocompetent Cells Market by Product Type
 9.5.5.2.2 Argentina Electrocompetent Cells Market by End users/Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ELECTROCOMPETENT CELLS MARKET
 10.1 North America
 10.2 Europe
 10.3 Asia-Pacific
 10.4 Middle East and Africa
 10.5 South and Central America
11. INDUSTRY LANDSCAPE
 11.1. MERGERS AND ACQUISITIONS
 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 11.3. NEW PRODUCT LAUNCHES
 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ELECTROCOMPETENT CELLS MARKET, KEY COMPANY PROFILES
 12.1. AGILENT TECHNOLOGIES
 12.1.1. Key Facts
 12.1.2. Business Description
 12.1.3. Products and Services
 12.1.4. Financial Overview
 12.1.5. SWOT Analysis
 12.1.6. Key Developments
 12.2. BEIJING TRANSGEN BIOTECHM
 12.2.1. Key Facts
 12.2.2. Business Description
 12.2.3. Products and Services
 12.2.4. Financial Overview
 12.2.5. SWOT Analysis
 12.2.6. Key Developments
 12.3. BIO-RAD LABORATORIES
 12.3.1. Key Facts
 12.3.2. Business Description
 12.3.3. Products and Services
 12.3.4. Financial Overview
 12.3.5. SWOT Analysis
 12.3.6. Key Developments
 12.4. GENESCRIPT CORPORATION
 12.4.1. Key Facts
 12.4.2. Business Description
 12.4.3. Products and Services
 12.4.4. Financial Overview
 12.4.5. SWOT Analysis
 12.4.6. Key Developments
 12.5. MERCK KGAA
 12.5.1. Key Facts
 12.5.2. Business Description
 12.5.3. Products and Services
 12.5.4. Financial Overview
 12.5.5. SWOT Analysis
 12.5.6. Key Developments
 12.6. NEW ENGLAND BIOLABS
 12.6.1. Key Facts
 12.6.2. Business Description
 12.6.3. Products and Services
 12.6.4. Financial Overview
 12.6.5. SWOT Analysis
 12.6.6. Key Developments
 12.7. ORIGENE TECHNOLOGIES
 12.7.1. Key Facts
 12.7.2. Business Description
 12.7.3. Products and Services
 12.7.4. Financial Overview
 12.7.5. SWOT Analysis
 12.7.6. Key Developments
 12.8. PROMEGA CORPORATION
 12.8.1. Key Facts
 12.8.2. Business Description
 12.8.3. Products and Services
 12.8.4. Financial Overview
 12.8.5. SWOT Analysis
 12.8.6. Key Developments
 12.9. QIAGEN N.V.
 12.9.1. Key Facts
 12.9.2. Business Description
 12.9.3. Products and Services
 12.9.4. Financial Overview
 12.9.5. SWOT Analysis
 12.9.6. Key Developments
 12.10. THERMO FISHER SCIENTIFIC
 12.10.1. Key Facts
 12.10.2. Business Description
 12.10.3. Products and Services
 12.10.4. Financial Overview
 12.10.5. SWOT Analysis
 12.10.6. Key Developments
 12.11. ZYMO RESEARCH
 12.11.1. Key Facts
 12.11.2. Business Description
 12.11.3. Products and Services
 12.11.4. Financial Overview
 12.11.5. SWOT Analysis
 12.11.6. Key Developments
13. APPENDIX
 13.1. ABOUT THE INSIGHT PARTNERS
 13.2. GLOSSARY OF TERMS

 

The List of Companies

1. Merck KGaA
2. Promega Corporation
3. Takara Bio, Inc.
4. New England Biolabs
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies
7. Illumina, Inc.
8. Qiagen
9. Genscript
10. Origene Technologies, Inc.
11. GenScript Biotech Corporation
12. Scarab Genomics, LLC
13. Meridian Bioscience, Inc.
14. Delphi Genetics S.A.

 

TIPBT00002547
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking